DealCollabConnecting People, Possibilities and Deals
Share
Age (T)
0 days live
Forwards (F)
3 forwards
Advisors (D)
1 advisor
AcquisitionACQUISITION OPPORTUNITY

Acquisition Opportunity in Pharmaceuticals Sector

A well-funded strategic investor seeks to acquire a profitable pharmaceutical or healthcare business in India. Target companies should have a minimum annual turnover of ₹50 Crore and be EBITDA positive.

Pharmaceutical Formulations & APIs · Chennai, Hyderabad, Bengaluru

Pharma & chemicals
Annual revenue
₹50 Cr

Business overview

Buyer Profile:A well-funded strategic investor

A well-funded strategic investor seeks to acquire a profitable pharmaceutical or healthcare business in India. Target companies should have a minimum annual turnover of ₹50 Crore and be EBITDA positive.

Market position

Buyer profile: A well-funded strategic investor

Products & services

  • Generic Pharma
  • Biotech
  • Biopharma
  • OTC
  • Consumer-Health products

Business highlights

Competitive advantages

  • Minimum 5+ years of operational history required
  • Must be EBITDA and profit after tax positive
  • Strong growth potential and scalability sought
  • Established market presence and product portfolio preferred
  • Clear transition triggers for promoters

Transaction details

Type
Acquisition
Structure
Acquisition

Counterparty profile

Sought by the mandate

  • Promoters of pharmaceutical businesses
  • Advisors representing sell-side opportunities

Qualification criteria

  • Minimum annual turnover of ₹50 Crore+
  • EBITDA positive companies only
  • Minimum 5+ years of operational history
Shared byTushar Deshmukh

Contact details are shared only after the deal owner approves an expression of interest.

Confidential|No company name disclosed|Powered by DealCollab
DealCollab